Prazosin HCl Anhydrous
Prazosin is an alpha-blocker that causes a decrease in total peripheral resistance and is used to treat hypertension. Prazosin is marketed by Pfizer and was initially approved by the FDA in 1988 It belongs to the class of drugs known as alpha-1 antagonists Label.
Systematic Name
2-[4-(furan-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine hydrochloride
Therapeutic Category
Anti-hypertensive
Suitable Formulations
Solid
Approvals
DMF Ready
